Grant: Collaborative Health Research Projects (NSERC partnered)
University of Toronto
$203,674.00
Surface-oriented antibody capture of endothelial progenitor cells for the reduction of post-stent restenosis
FY 2011-12
Summary
"Atherosclerosis involves the deposition of plaque on the interior walls of arterial vessels and results in the narrowing or stenosis of arteries. Although successful, often-used angioplasty suffers from non-uniform arterial widening and restenosis due to post-surgical recoil of the artery. To mitigate these shortcomings, stenting has been used as an alternative in suitable candidates. Stents are expandable cylindrical scaffolds that are implanted within narrowed arteries. They are typically constructed from medical grade stainless steel and can be implanted as bare metal stents (BMS), or as drug eluting stents (DES) depending on patient candidacy.
Despite the advantages of BMS/DES over angioplasty, their effectiveness remains limited by complications associated with biocompatibility. For instance, post-stent restenosis due to neointimal hyperplasia (cellular hypertrophy, proliferation and deposition of extracellular matrix on the stent and around the site of implantation) remains a significant problem. In light of the challenges that both BMS and DES face, further research into alternative strategies for the reduction of both NH and physiological attack of the stent surface is warranted. A promising alternative to BMS and DES is an antibody-based coating that is capable of capturing endothelial progenitor cells (EPCs). EPCs are attractive targets for the reduction of NH since they are present in the bloodstream and have been found to participate in the re-endothelialization of damaged arterial vessels and the inhibition of neointima formation. An early version of this involves a polymer layer on the device and indiscriminate binding of protein.
This proposal concerns a new approach for stent surface modification that incorporates control of both the interfacial population of antibodies, and their correct orientation for optimal binding of EPCs. The Thompson group has examined the surface chemistry of medical grade stainless steel using atomic force microscopy
(AFM) and x-ray photoelectron spectroscopy (XPS) with a focus on the formation of surface hydroxyl (-OH)"
Department
Program
Collaborative Health Research Projects (NSERC partnered)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
248260
Name
Thompson Michael
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Surface-oriented antibody capture of endothelial progenitor cells for the reduction of post-stent restenosis
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$203,674
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Antibody Immobilization; Biocompatibility; Endothelial Cell Capture; Self Assembled Monolayer; Stent Devices; Surface Chemistry
Abstract
"Atherosclerosis involves the deposition of plaque on the interior walls of arterial vessels and results in the narrowing or stenosis of arteries. Although successful, often-used angioplasty suffers from non-uniform arterial widening and restenosis due to post-surgical recoil of the artery. To mitigate these shortcomings, stenting has been used as an alternative in suitable candidates. Stents are expandable cylindrical scaffolds that are implanted within narrowed arteries. They are typically constructed from medical grade stainless steel and can be implanted as bare metal stents (BMS), or as drug eluting stents (DES) depending on patient candidacy.
Despite the advantages of BMS/DES over angioplasty, their effectiveness remains limited by complications associated with biocompatibility. For instance, post-stent restenosis due to neointimal hyperplasia (cellular hypertrophy, proliferation and deposition of extracellular matrix on the stent and around the site of implantation) remains a significant problem. In light of the challenges that both BMS and DES face, further research into alternative strategies for the reduction of both NH and physiological attack of the stent surface is warranted. A promising alternative to BMS and DES is an antibody-based coating that is capable of capturing endothelial progenitor cells (EPCs). EPCs are attractive targets for the reduction of NH since they are present in the bloodstream and have been found to participate in the re-endothelialization of damaged arterial vessels and the inhibition of neointima formation. An early version of this involves a polymer layer on the device and indiscriminate binding of protein.
This proposal concerns a new approach for stent surface modification that incorporates control of both the interfacial population of antibodies, and their correct orientation for optimal binding of EPCs. The Thompson group has examined the surface chemistry of medical grade stainless steel using atomic force microscopy
(AFM) and x-ray photoelectron spectroscopy (XPS) with a focus on the formation of surface hydroxyl (-OH)"
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Thompson, Michael
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $203,674~ $0~